Adverse drug reactions with positive rechallenge: a retrospective analysis of cases through a hospital pharmacovigilance program

被引:0
|
作者
Hladun Alvaro, O. [1 ]
Farre Albaladejo, M. [1 ,2 ]
Montane Esteva, E. [1 ,2 ]
机构
[1] Germans Trias & Pujol Hosp, Clin Pharmacol Dept, Badalona, Spain
[2] Autonomous Univ Barcelona, Pharmacol Therapeut & Toxicol Dept, Cerdanyola Del Valles, Spain
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
131
引用
收藏
页码:S115 / S115
页数:1
相关论文
共 50 条
  • [31] Adverse drug reactions profiles for abiraterone and enzalutamide: A pharmacovigilance descriptive analysis
    Scailteux, Lucie-Marie
    Lacroix, Clemence
    Bergeron, Sandrine
    Despas, Fabien
    Sassier, Marion
    Triquet, Louise
    Picard, Sylvie
    Oger, Emmanuel
    Polard, Elisabeth
    THERAPIE, 2021, 76 (05): : 455 - 465
  • [32] HOSPITAL PHARMACY PROGRAM FOR REPORTING ADVERSE DRUG-REACTIONS
    JACINTO, MS
    KLEINMANN, K
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1983, 40 (03): : 444 - 445
  • [33] Neonatal adverse drug reactions: an analysis of reports to the French pharmacovigilance database
    Kaguelidou, Florentia
    Beau-Salinas, Frederique
    Jonville-Bera, Annie Pierre
    Jacqz-Aigrain, Evelyne
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 82 (04) : 1058 - 1068
  • [34] Adverse Drug Reactions to β-Lactam Antibiotics: A Portuguese Pharmacovigilance Database Analysis
    Silva, M.
    Fernandes, J. P.
    Parracha, E. Ribeiro
    Gamboa, A.
    Alves, C. Lima
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2024, 34
  • [35] Spontaneous reports of adverse drug reactions: A retrospective analysis using the Portuguese Southern Regional Pharmacovigilance Unit database
    Pinheiro, L. C.
    Caneira, M.
    Martins, A. P.
    Cabrita, J.
    Morais, J. A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S126 - S126
  • [36] Patterns of adverse drug reactions in Jordan: a retrospective analysis of the National Pharmacovigilance Data Registry (2015-2021)
    Mhaidat, Nizar M.
    Alshogran, Osama Y.
    Altawalbeh, Shoroq M.
    Jaber, Jaber M.
    Banat, Hayaa A.
    Ahmad, Dana S.
    Alabsi, Worood
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (10) : 957 - 965
  • [37] Underreporting Adverse Drug Reactions (ADR) and Medication Errors (ME): a Problem in Hospital Pharmacovigilance
    Garza-Ocanas, L.
    Escobedo Pena, J.
    Gonzalez-Nieto, C.
    Perez-Rodriguez, E.
    Guzman-Lopez, S.
    Aponte, E.
    Riojas-Hernandez, P.
    DRUG SAFETY, 2015, 38 (10) : 985 - 985
  • [38] Cutaneous adverse drug reactions notified by pharmacovigilance in a tertiary care hospital in north India
    Mittal, Niti
    Gupta, Mahesh
    Singla, Mohit
    CUTANEOUS AND OCULAR TOXICOLOGY, 2014, 33 (04) : 289 - 293
  • [39] Evaluation of adverse drug reactions in a pharmacy department: four years of experience of a pharmacovigilance program
    Furelos, Tania Gonzalez
    Legazpi, Iria Rodriguez
    Bueno, Eva Fraga
    Lopez, Monica Granero
    Penin, Isaura Rodriguez
    PHARMACEUTICAL CARE ESPANA, 2025, 27
  • [40] Adverse drug reactions reporting: Pharmacovigilance knowledge of general public in a regional university hospital
    Bres, V.
    Deshormiere, N.
    Philibert, C.
    Lebrun, J.
    Perosa, C.
    Nouailles, M. Teulon
    Robin, V.
    Pinzani, V.
    Hillaire-Buys, D.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 : 61 - 61